scispace - formally typeset
Open AccessJournal ArticleDOI

Involvement of Rho GTPases in the Transcriptional Inhibition of Preproendothelin-1 Gene Expression by Simvastatin in Vascular Endothelial Cells

Reads0
Chats0
TLDR
The basal transcription rate of the preproendothelin-1 gene was decreased by simvastatin in bovine aortic endothelial cells and the Rho proteins play an essential role in the control of vascular tone and proliferative response.
Abstract
—Endothelial dysfunction is characterized by an impaired vasodilatory response to endothelial agonists as well as by alterations in adhesion and coagulation processes. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors (statins) have been shown to be useful in the reversal of endothelial dysfunction, an effect that may be independent of the reduction in cholesterol levels. Both the l-arginine–nitric oxide–cGMP and endothelin pathways are involved in the regulation of vascular tone. Here, we show that the basal transcription rate of the preproendothelin-1 gene was decreased by simvastatin (10 μmol/L) in bovine aortic endothelial cells. Transfection studies with the preproendothelin-1 gene promoter showed that mevalonate (100 μmol/L) was able to prevent the inhibitory effect mediated by simvastatin. Protein geranylgeranylation, but not farnesylation, proved to be crucial for a correct expression of the preproendothelin-1 gene. The C3 exotoxin from Clostridium botulinum that selectively inactivates Rho GTPases, the processing of which involves geranylgeranylation, reproduced the inhibitory effect of simvastatin on the expression of preproendothelin-1. Overexpression of dominant-negative mutants of RhoA and RhoB led to a significant reduction in the preproendothelin-1 promoter activity, whereas the expression of wild-type and constitutively active forms of these proteins resulted in an increase, in support that Rho proteins are required for the basal expression of the preproendothelin-1 gene. Finally, we show that the Rho-dependent activation of the preproendothelin-1 gene transcription was inhibited by simvastatin. Thus, the control of vascular tone and proliferative response mediated by endothelin-1 is regulated at multiple levels, among which the Rho proteins play an essential role.

read more

Citations
More filters

Drug Design, Development and Therapy

TL;DR: It is possible to predict which patients are at a higher risk of developing liver chemistry signals using pretreatment (baseline) data, and the type of analysis described here could help determine whether new biomarkers offer improved performance over established ones.
Journal ArticleDOI

Statins Have Biphasic Effects on Angiogenesis

TL;DR: HMG-CoA reductase inhibition has a biphasic dose-dependent effect on angiogenesis that is lipid independent and associated with alterations in endothelial apoptosis and vascular endothelial growth factor signaling.
Journal ArticleDOI

Pleiotropic effects of statin therapy: molecular mechanisms and clinical results

TL;DR: Data from recent clinical trials are reviewed that support the concept of statin pleiotropy and provide a rationale for their clinical importance.
Journal ArticleDOI

Isoprenoids as mediators of the biological effects of statins

TL;DR: Evidence indicates that some of the cholesterol-independent, or so-called pleiotropic, effects of statins involve improving or restoring endothelial function, enhancing the stability of atherosclerotic plaques, decreasing oxidative stress and inflammation, and inhibiting the thrombogenic response in the vascular wall.
Journal ArticleDOI

Statin effects beyond lipid lowering—are they clinically relevant?

TL;DR: The striking benefit achieved with statin treatment in patients with a wide range of cholesterol levels, which cannot be attributed to their cholesterol lowering effect alone, has raised the question about the possible presence of additional effects of statins beyond their impact on serum cholesterol levels.
References
More filters
Journal ArticleDOI

Regulation of the mevalonate pathway.

TL;DR: The mevalonate pathway produces isoprenoids that are vital for diverse cellular functions, ranging from cholesterol synthesis to growth control, and could be useful in treating certain forms of cancer as well as heart disease.
Journal ArticleDOI

Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors

TL;DR: Findings suggest that HMG CoA reductase inhibitors may have beneficial effects in atherosclerosis beyond that attributed to the lowering of serum cholesterol by increasing ecNOS activity.
Journal ArticleDOI

The Rho family GTPases RhoA, Racl , and CDC42Hsregulate transcriptional activation by SRF

TL;DR: Results establish SRF as a nuclear target of a novel Rho-mediated signaling pathway that does not correlate with activation of the MAP kinases ERK, SAPK/JNK, or MPK2/p38.
Journal ArticleDOI

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.

TL;DR: Cholesterol lowering with lovastatin significantly improved endothelium-mediated responses in the coronary arteries of patients with atherosclerosis, and improvement in the local regulation of coronary arterial tone could potentially relieve ischemic symptoms and signal the stabilization of the atherosclerotic plaque.
Journal ArticleDOI

Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.

TL;DR: Endothelin is released from the intimal layer of intact blood vessels, both under basal conditions and after stimulation withThrombin and the calcium ionophore A23187, and endothelium-derived nitric oxide released during stimulation with thrombin inhibits the production of the peptide via a cyclic GMP-dependent pathway.
Related Papers (5)